Bristol-Myers Squibb Company 13D and 13G filings for Celularity Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:10 pm Sale |
2024-12-31 | 13G | Celularity Inc. CELU |
BRISTOL MYERS SQUIBB CO BMY |
426,372 1.900% |
-768,955 (-64.33%) |
Filing |
| 2021-07-26 5:10 pm Purchase |
2021-07-16 | 13G | Celularity Inc. CELU |
BRISTOL MYERS SQUIBB CO BMY |
1,195,327 9.900% |
1,195,327 (New Position) |
Filing |